文献速递神经肿瘤

硼中子俘获治疗后高级别胶质瘤的脑脊液播散在IDH1R132H突变阴性胶质母细胞瘤的小细胞亚型中更常见

Cerebrospinal fluid dissemination of high-grade gliomas following boron neutron capture therapy occurs more frequently in the small cell subtype of IDH1R132H mutation-negative glioblastoma.
PubMed 文献 · J Neurooncol · 2017-05-22

研究纳入2002年1月至2013年7月在日本接受硼中子俘获治疗(BNCT)的87例幕上高级别胶质瘤患者(新诊断41例、复发46例),其中30例出现脑脊液播散(CSFD)。对30例中20例有病理切片的患者行Ki-67与IDH1R132H免疫组化,发现10例为IDH1R132H阴性小细胞胶质母细胞瘤,提示此类肿瘤经脑脊液播散的倾向增加。

要点

  • 87例接受BNCT的幕上高级别胶质瘤患者中30例发生脑脊液播散,为该队列最常见死因
  • 20例可评估患者中10例为IDH1R132H阴性小细胞胶质母细胞瘤
  • IDH1R132H阴性胶质母细胞瘤尤其小细胞亚型在脑脊液播散患者中占比过高

核心结论

  • IDH1R132H阴性胶质母细胞瘤尤其小细胞胶质母细胞瘤在发生脑脊液播散的患者中占比过高,提示这类肿瘤在BNCT后经脑脊液播散的倾向增加,且这些患者该严重临床事件风险高。

研究设计与样本

  • 研究为日本单中心接受BNCT治疗的高级别胶质瘤患者队列,共87例幕上高级别胶质瘤,其中新诊断41例、复发46例,治疗时间为2002年1月至2013年7月。
  • 30例发生脑脊液播散的患者中,对20例有病理切片者评估了BNCT前肿瘤组织学及Ki-67、IDH1R132H免疫组化。
  • 对3例IDH1R132H阳性与1例对照IDH1R132H阴性肿瘤行荧光原位杂交(FISH)以确定染色体1p和19q状态。

主要发现

  • 87例中30例发生蛛网膜下腔或脑室内脑脊液播散,为该队列患者最常见死因。
  • 20例可评估患者中10例为IDH1R132H阴性小细胞胶质母细胞瘤,其余为其他IDH1R132H阴性胶质母细胞瘤变异型、1例IDH1R132H阳性胶质母细胞瘤和2例间变性少突胶质细胞瘤。
  • Ki-67免疫阳性范围为2%至75%。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We have used boron neutron capture therapy (BNCT) to treat patients in Japan with newly diagnosed or recurrent high-grade gliomas and have observed a significant increase in median survival time following BNCT. Although cerebrospinal fluid dissemination (CSFD) is not usually seen with the current standard therapy of patients with glioblastoma (GBM), here we report that subarachnoid or intraventricular CSFD was the most frequent cause of death for a cohort of our patients with high-grade gliomas who had been treated with BNCT. The study population consisted of 87 patients with supratentorial high-grade gliomas; 41 had newly diagnosed tumors and 46 had recurrent tumors. Thirty of 87 patients who were treated between January 2002 and July 2013 developed CSFD. Tumor histology before BNCT and immunohistochemical staining for two molecular markers, Ki-67 and IDH1R132H, were evaluated for 20 of the 30 patients for whom pathology slides were available. Fluorescence in situ hybridization (FISH) was performed on 3 IDH1R132H-positive and 1 control IDH1R132H-negative tumors in order to determine chromosome 1p and 19q status. Histopathologic evaluation revealed that 10 of the 20 patients' tumors were IDH1R132H-negative small cell GBMs. The remaining patients had tumors consisting of other IDH1R132H-negative GBM variants, an IDH1R132H-positive GBM and two anaplastic oligodendrogliomas. Ki-67 immunopositivity ranged from 2 to 75%. In summary, IDH1R132H-negative GBMs, especially small cell GBMs, accounted for a disproportionately large number of patients who had CSF dissemination. This suggests that these tumor types had an increased propensity to disseminate via the CSF following BNCT and that these patients are at high risk for this clinically serious event.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Kondo N, Barth RF, Miyatake SI, et al. Cerebrospinal fluid dissemination of high-grade gliomas following boron neutron capture therapy occurs more frequently in the small cell subtype of IDH1R132H mutation-negative glioblastoma. J Neurooncol. 2017. PMID: 28534152. doi:10.1007/s11060-017-2408-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。